Prosecution Insights
Last updated: April 19, 2026

Nanjing Bioheng Biotech Co. Ltd.

4 pending office actions

Portfolio Summary

4
Total Pending OAs
1
Final Rejections
3
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18016203 NOVEL CO-STIMULATORY DOMAIN AND USE THEREOF SUNSHINE, HANNAH LOUISE 1647 Non-Final OA Jan 13, 2023
18015544 ENGINEERED IMMUNE CELL FOR ALLOTRANSPLANTATION PETERS, ALEC JON 1641 Non-Final OA Jan 11, 2023
17910007 ENGINEERED IMMUNE CELL EXPRESSING NK INHIBITORY MOLECULE AND USE THEREOF MOSELEY II, NELSON B 1642 Non-Final OA Sep 08, 2022
17802242 NOVEL CHIMERIC ANTIGEN RECEPTOR AND USE THEREOF PETERS, ALEC JON 1641 Final Rejection Aug 25, 2022

Managing Nanjing Bioheng Biotech Co. Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month